Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
In this article, Charlotte Blease argues that patient access to online shared clinical notes (also called ‘open notes’) may cause or exacerbate nocebo effects in two ways.1
First, open notes may enhance patient understanding about the adverse effects of medications and treatments. However, reading information about adverse effects may lead patients to form negative expectations that, in turn, may cause or worsen symptoms via nocebo mechanisms.
Second, open notes may paradoxically lower the quality of the therapeutic relationship by allowing patients to detect signs of discrimination and stigma in clinical notes. By accessing their shared notes, patients may identify (or think that they are identifying) signs of stigmatisation and discrimination in clinicians’ words. This may diminish their trust while increasing their anxieties and fears, all factors that have been associated with enhanced nocebo effects.
The article then suggests different strategies to mitigate nocebo effects while using open notes, highlighting the need for more empirical research. This call for more empirical research is crucial, as most of Blaise’s conclusions rest on limited or indirect empirical evidence. Rather than being a shortcoming of the argument per se, however, this is …
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Sharing online clinical notes with patients: implications for nocebo effects and health equity
- Open notes in patient care: confining deceptive placebos to the past?
- Placebo effects and racial and ethnic health disparities: an unjust and underexplored connection
- Unethical informed consent caused by overlooking poorly measured nocebo effects
- How factual do we want the facts? Criteria for a critical appraisal of empirical research for use in ethics
- Old problems in need of new (narrative) approaches? A young physician–bioethicist’s search for ethical guidance in the practice of physician-assisted dying in the Netherlands
- Digital bioethics: introducing new methods for the study of bioethical issues
- Response to commentaries on sharing online clinical notes with patients: implications for nocebo effects and health equity
- Is there a nocebo response that results from disease awareness campaigns and advertising in Australia, and can this effect be mitigated?
- Placebo effects and the molecular biological components involved